Key facts
- Vironix Health’s last known valuation is $1.4M (Dec 2021).
- It has raised $3.6M; the latest was Later Stage VC ($1.9M) in Aug 2025.
- Notable investors include Keiretsu Forum, RAD Diversified.
- Vironix Health has filed 3 Form Ds with the SEC since 2021, most recently May 2023 ($40K sold to 2 investors).
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Vironix Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Vironix Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vironix Health
Developer of a virtual care management platform designed to provide doctors with the tools to monitor their patients at home. The company's platform offers a comprehensive remote care service, including remote patient monitoring, remote therapeutic monitoring, chronic care management, primary care management, and complex chronic care management, enabling healthcare providers to deliver care remotely, improving patient outcomes and reducing costs.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2020
- Employees
- 44
- Website
- vironix.ai/
- Ownership
- Privately Held (backing)
Vironix Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vironix Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vironix Health in its N-PORT filings yet. We sweep new filings monthly.